Quodlibet Naturopathics
caryophyllene oxide
No description available.
caryophyllene oxide may relate to these other naturopathic agents:
Cinnamon (Cinnamomum spp.)
[article]
[profile]
Guava
[article]
[profile]
Clove
[article]
[profile]
Oregano
[article]
[profile]
Pepper, Black
[article]
[profile]
caryophyllene oxide is linked to these entities, through the following networks:
AKT
The Warburg Effect
Fc gamma R-mediated phagocytosis
B cell receptor signaling pathway
Fc epsilon RI signaling pathway
Jak-STAT signaling pathway
Chemokine signaling pathway
Insulin signaling pathway
Hormesis and adaptive cellular stress response pathways
Adipocytokine signaling pathway
Neurotrophin signaling pathway
Toll-like receptor signaling pathway
NF-kB Signaling Pathway
MTOR signaling pathway
The mitogen-activated protein kinase (MAPK) cascade
CASP3
The Warburg Effect
Apoptosis
Bisphenol A (BPA): Metabolic effects and degradation
Pathways in Cancer
p53 signaling pathway
Alzheimer's disease
Colorectal cancer
The mitogen-activated protein kinase (MAPK) cascade
ERK
B cell receptor signaling pathway
VEGF signaling pathway
NOD-like receptor signaling pathway
Pathways in Cancer
Fc epsilon RI signaling pathway
TGF-beta signaling pathway
Colorectal cancer
Toll-like receptor signaling pathway
JNK
NOD-like receptor signaling pathway
Pathways in Cancer
Fc epsilon RI signaling pathway
ErbB signaling pathway
Insulin signaling pathway
Focal adhesion
Wnt signaling pathway
Adipocytokine signaling pathway
Colorectal cancer
GnRH signaling pathway
Neurotrophin signaling pathway
Toll-like receptor signaling pathway
The mitogen-activated protein kinase (MAPK) cascade
MTOR
The Warburg Effect
Acute myeloid leukemia
Autophagy
Pathways in Cancer
ErbB signaling pathway
Insulin signaling pathway
Adipocytokine signaling pathway
PTEN Sensing Pathway
MTOR signaling pathway
caryophyllene oxide references used by Quodlibet:
β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation.
Cancer Lett
2011 Dec 22;312(2):178-88